CG Oncology (CGON) Amortizatization of Intangibles (2023 - 2025)
CG Oncology posted quarterly Amortizatization of Intangibles of -$951000.0 for Q4 2025, up 24.22% year-on-year from -$765558.1 in Q4 2024, and down 373.13% on a QoQ basis from -$201000.0 in Q3 2025.
CG Oncology (CGON) has 3 years of Amortizatization of Intangibles data on file, last reported at -$951000.0 in Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles rose 24.22% year-over-year to -$951000.0; the trailing twelve-month figure through Dec 2025 stood at $1.0 million (down 79.69% YoY), and the FY2025 full-year result was $1.0 million, down 79.69% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at -$951000.0, down from -$201000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.5 million in Q2 2024 and bottomed at -$1.3 million in Q4 2024.
- The 3-year median for Amortizatization of Intangibles is $1.3 million (2023), against an average of $862400.0.
- Peak annual rise in Amortizatization of Intangibles reached 37.33% in 2024, while the deepest fall reached 185.61% in 2024.
- A 3-year view of Amortizatization of Intangibles shows it stood at $1.5 million in 2023, then plunged by 185.61% to -$1.3 million in 2024, then grew by 24.22% to -$951000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at -$951000.0 (Q4 2025), -$201000.0 (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | CG Oncology | 5.01 Bn | 5.01 Bn | -1.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -951,000.00 |
| Dec 31, 2025 | -951,000.00 |
| Sep 30, 2025 | -201,000.00 |
| Sep 30, 2025 | -201,000.00 |
| Jun 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | 279,000.00 |
| Mar 31, 2025 | 279,000.00 |
| Dec 31, 2024 | -1.26 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 1.15 Mn |
| Sep 30, 2023 | 1.15 Mn |